Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

NCT00162734 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Daily Infergen (Interferon Alfacon-1, CIFN) (9 or 15 µg) + Ribavirin (1000-1200 mg, based on body weight) PO Daily for up to 48 wks

Sponsor

Bausch Health Americas, Inc.